Hap Trading, LLC Unity Biotechnology, Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$0.4 - $4.27 $520 - $5,550	1,300 Added 9.7%	14,700 $0
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.29 $1,344 - $3,096	-2,400 Reduced 15.19%	13,400 $0
Q1 2022 May 12, 2022	SELL	$0.72 - $1.86 $1,872 - $4,836	-2,600 Reduced 14.13%	15,800 $3,000
Q4 2021 Feb 14, 2022	BUY	$1.3 - $3.17 $23,920 - $58,328	18,400 New	18,400 $3,000
Q1 2021 May 14, 2021	SELL	$5.51 - $9.42 $84,303 - $144,126	-15,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $52,326 - $97,308	15,300 New	15,300 $21,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.